BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28060727)

  • 1. Associations between genetic variants in immunoregulatory genes and risk of non-Hodgkin lymphoma in a Chinese population.
    Ye X; Zhao K; Wu C; Hu P; Fu H
    Oncotarget; 2017 Feb; 8(6):10450-10457. PubMed ID: 28060727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium.
    Skibola CF; Bracci PM; Nieters A; Brooks-Wilson A; de Sanjosé S; Hughes AM; Cerhan JR; Skibola DR; Purdue M; Kane E; Lan Q; Foretova L; Schenk M; Spinelli JJ; Slager SL; De Roos AJ; Smith MT; Roman E; Cozen W; Boffetta P; Kricker A; Zheng T; Lightfoot T; Cocco P; Benavente Y; Zhang Y; Hartge P; Linet MS; Becker N; Brennan P; Zhang L; Armstrong B; Smith A; Shiao R; Novak AJ; Maynadie M; Chanock SJ; Staines A; Holford TR; Holly EA; Rothman N; Wang SS
    Am J Epidemiol; 2010 Feb; 171(3):267-76. PubMed ID: 20047977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors.
    Wang SS; Cozen W; Cerhan JR; Colt JS; Morton LM; Engels EA; Davis S; Severson RK; Rothman N; Chanock SJ; Hartge P
    Cancer Res; 2007 May; 67(10):5042-54. PubMed ID: 17510437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL10 and TNF variants and risk of non-Hodgkin lymphoma among three Asian populations.
    Hosgood HD; Au WY; Kim HN; Liu J; Hu W; Tse J; Song B; Wong KF; Lee JJ; Chanock SJ; Siu LP; Purdue MP; Shin MH; Yu J; Liang R; Kim HJ; Rothman N; Lan Q
    Int J Hematol; 2013 Jun; 97(6):793-9. PubMed ID: 23640160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma.
    Cerhan JR; Liu-Mares W; Fredericksen ZS; Novak AJ; Cunningham JM; Kay NE; Dogan A; Liebow M; Wang AH; Call TG; Habermann TM; Ansell SM; Slager SL
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3161-9. PubMed ID: 18990758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma risk.
    Wang SS; Purdue MP; Cerhan JR; Zheng T; Menashe I; Armstrong BK; Lan Q; Hartge P; Kricker A; Zhang Y; Morton LM; Vajdic CM; Holford TR; Severson RK; Grulich A; Leaderer BP; Davis S; Cozen W; Yeager M; Chanock SJ; Chatterjee N; Rothman N
    PLoS One; 2009; 4(4):e5360. PubMed ID: 19390683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium.
    Rothman N; Skibola CF; Wang SS; Morgan G; Lan Q; Smith MT; Spinelli JJ; Willett E; De Sanjose S; Cocco P; Berndt SI; Brennan P; Brooks-Wilson A; Wacholder S; Becker N; Hartge P; Zheng T; Roman E; Holly EA; Boffetta P; Armstrong B; Cozen W; Linet M; Bosch FX; Ennas MG; Holford TR; Gallagher RP; Rollinson S; Bracci PM; Cerhan JR; Whitby D; Moore PS; Leaderer B; Lai A; Spink C; Davis S; Bosch R; Scarpa A; Zhang Y; Severson RK; Yeager M; Chanock S; Nieters A
    Lancet Oncol; 2006 Jan; 7(1):27-38. PubMed ID: 16389181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variation in chromosomal translocation breakpoint and immune function genes and risk of non-Hodgkin lymphoma.
    Fernberg P; Chang ET; Duvefelt K; Hjalgrim H; Eloranta S; Sørensen KM; Porwit A; Humphreys K; Melbye M; Ekström Smedby K
    Cancer Causes Control; 2010 May; 21(5):759-69. PubMed ID: 20087644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms in pattern-recognition genes in the innate immunity system and risk of non-Hodgkin lymphoma.
    Hu W; Bassig BA; Xu J; Zheng T; Zhang Y; Berndt SI; Holford TR; Hosgood HD; Leaderer B; Yeager M; Menashe I; Boyle P; Zou K; Zhu Y; Chanock S; Lan Q; Rothman N
    Environ Mol Mutagen; 2013 Jan; 54(1):72-7. PubMed ID: 23055202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor-α induced protein 8 polymorphism and risk of non-Hodgkin's lymphoma in a Chinese population: a case-control study.
    Zhang Y; Wang MY; He J; Wang JC; Yang YJ; Jin L; Chen ZY; Ma XJ; Sun MH; Xia KQ; Hong XN; Wei QY; Zhou XY
    PLoS One; 2012; 7(5):e37846. PubMed ID: 22666399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphotoxin alpha (LTA) polymorphism is associated with prognosis of non-Hodgkin's lymphoma in a Chinese population.
    Zhang Y; Chen MB; Zhou XY; Hong XN
    PLoS One; 2013; 8(6):e66411. PubMed ID: 23840460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The +252A/G polymorphism in the Lymphotoxin-α gene and the risk of non-Hodgkin lymphoma: a meta-analysis.
    Cao C; Liu S; Lou SF; Liu T
    Eur Rev Med Pharmacol Sci; 2014; 18(4):544-52. PubMed ID: 24610621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of interleukin-10 promoter single nucleotide polymorphisms and risk of non-Hodgkin lymphoma in a Malaysian population.
    Lim YY; Chin YM; Tai MC; Fani S; Chang KM; Ong TC; Bee PC; Gan GG; Ng CC
    Leuk Lymphoma; 2015 Jan; 56(1):163-8. PubMed ID: 24684230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of genome-wide association study-identified genetic variants for non-Hodgkin lymphoma in a Chinese population.
    Qiao Y; Zhou Y; Wu C; Zhai K; Han X; Chen J; Tian X; Chang J; Lu Z; Zhang B; Yu D; Yao J; Shi Y; Tan W; Lin D
    Carcinogenesis; 2013 Jul; 34(7):1516-9. PubMed ID: 23455380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin Lymphoma Study.
    Purdue MP; Lan Q; Kricker A; Grulich AE; Vajdic CM; Turner J; Whitby D; Chanock S; Rothman N; Armstrong BK
    Carcinogenesis; 2007 Mar; 28(3):704-12. PubMed ID: 17056605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of non-Hodgkin Lymphoma (NHL) risk with autoimmune conditions according to putative NHL loci.
    Wang SS; Vajdic CM; Linet MS; Slager SL; Voutsinas J; Nieters A; de Sanjose S; Cozen W; Alarcón GS; Martinez-Maza O; Brown EE; Bracci PM; Lightfoot T; Turner J; Hjalgrim H; Spinelli JJ; Zheng T; Morton LM; Birmann BM; Flowers CR; Paltiel O; Becker N; Holly EA; Kane E; Weisenburger D; Maynadie M; Cocco P; Foretova L; Staines A; Davis S; Severson R; Cerhan JR; Breen EC; Lan Q; Brooks-Wilson A; De Roos AJ; Smith MT; Roman E; Boffetta P; Kricker A; Zhang Y; Skibola C; Chanock SJ; Rothman N; Benavente Y; Hartge P; Smedby KE
    Am J Epidemiol; 2015 Mar; 181(6):406-21. PubMed ID: 25713336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different role of tumor necrosis factor-α polymorphism in non-Hodgkin lymphomas among Caucasian and Asian populations: a meta-analysis.
    Zhai K; Ding J; Zhou Y
    Int J Mol Sci; 2014 May; 15(5):7684-98. PubMed ID: 24857911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-1RN gene polymorphisms are associated with breast cancer risk in a Chinese Han population.
    Jin T; Cao W; Zuo X; Li M; Yang Y; Liang T; Yang H; Zhao X; Yang D
    J Gene Med; 2017 Dec; 19(12):. PubMed ID: 29047186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The functional TP53 rs1042522 and MDM4 rs4245739 genetic variants contribute to Non-Hodgkin lymphoma risk.
    Fan C; Wei J; Yuan C; Wang X; Jiang C; Zhou C; Yang M
    PLoS One; 2014; 9(9):e107047. PubMed ID: 25203442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms in DNA repair genes, hair dye use, and the risk of non-Hodgkin lymphoma.
    Guo H; Bassig BA; Lan Q; Zhu Y; Zhang Y; Holford TR; Leaderer B; Boyle P; Qin Q; Zhu C; Li N; Rothman N; Zheng T
    Cancer Causes Control; 2014 Oct; 25(10):1261-70. PubMed ID: 25178586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.